Covid-19

[Preprint] Maior estudo para obter dados sobre COVID longa identifica uma ampla lista de diagnósticos.

16 Jun, 2022 | 13:51h

Comentário do estudo: Largest study to date on long COVID identifies a broad list of diagnoses – News Medical

Estudo original: Understanding Post-Acute Sequelae of SARS-CoV-2 Infection through Data-Driven Analysis with Longitudinal Electronic Health Records: Findings from the RECOVER Initiative – medRxiv

 

Comentário no Twitter

🚨 The arguably largest #LongCovid study to date with millions of participants shows the increased risk of various symptoms after infection and the risk of having to take medications. https://t.co/DSvRcKVKIs pic.twitter.com/uUQxK1VQLv

— Jonas R. Kunst (@KunstJonas) May 23, 2022

 

---

Diferenças sexuais em características clínicas, estratégias de tratamento e desfechos de infarto agudo do miocárdio com elevação do segmento ST associado a COVID-19.

16 Jun, 2022 | 13:03h

Sex Differences in Clinical Characteristics, Management Strategies, and Outcomes of STEMI With COVID-19: NACMI Registry – JSCAI

Editorial: STEMIs and a Closer Look at MINOCA During the COVID-19 Pandemic – JSCAI

Vídeo: Conversations in Interventional Cardiology: NACMI Registry

Comunicado de imprensa: NACMI: International COVID-19 registry finds significant increased risk of in-hospital mortality for STEMI patients with COVID-19 compared to pre-pandemic – Society for Cardiovascular Angiography & Interventions

Comentário: Mystery MINOCA? Many COVID STEMIs Have No Culprit Lesion – TCTMD

---

Reduzindo o SARS-CoV-2 em ambientes fechados compartilhados.

14 Jun, 2022 | 13:57h

Reducing SARS-CoV-2 in Shared Indoor Air – JAMA

---

M-A | Eficácia e segurança da anticoagulação profilática padrão vs. intensificada em pacientes com Covid-19.

14 Jun, 2022 | 13:56h

Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with Covid-19: a systematic review and meta-analysis – Open Forum Infectious Diseases

Conteúdos relacionados:

Anticoagulants for people hospitalised with COVID‐19 – Cochrane Library

Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week – Journal of the American College of Cardiology

Point/Counterpoint: Should therapeutic heparin be administered to acutely ill hospitalized patients with COVID-19?

 

Comentário no Twitter

🆕💥💥Systematic review & meta-analysis @OFIDJournal Intensified anticoagulation has NO effect on mortality among hospitalised #COVID19 & ⬆️bleeding
Possible signal of mortality reduction for non-ICU patients although with low precision& high heterogeneity https://t.co/OqLYScxK53

— Antibiotic Steward Bassam Ghanem🆔🔥 (@ABsteward) June 7, 2022

 

---

M-A | Eficácia e danos do tocilizumabe no tratamento de pacientes com COVID-19.

14 Jun, 2022 | 13:54h

Efficacy and harms of tocilizumab for the treatment of COVID-19 patients: A systematic review and meta-analysis – PLOS One

---

Revisão de escopo | Consequências não intencionais das medidas implementadas no ambiente escolar para conter a pandemia de COVID-19.

14 Jun, 2022 | 13:20h

Unintended consequences of measures implemented in the school setting to contain the COVID‐19 pandemic: a scoping review – Cochrane Library

Resumo: Unintended consequences of school-based measures to manage the COVID-19 pandemic – Cochrane Library

---

Avaliação prospectiva da disfunção autonômica em pacientes com sequela pós-aguda de COVID-19.

14 Jun, 2022 | 13:18h

Prospective Evaluation of Autonomic Dysfunction in Post-Acute Sequela of COVID-19 – Journal of the American College of Cardiology

Comentário: Autonomic Dysfunction in Post-Acute Sequela of COVID-19 – American College of Cardiology

---

Metanálise com dados de pacientes individuais | Indicadores prognósticos e desfechos de pacientes internados por COVID-19 com doença neurológica.

14 Jun, 2022 | 13:17h

Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis – PLOS One

---

Suplemento | Infecção por Covid-19.

13 Jun, 2022 | 14:22h

Página principal: Covid-19 Infection – Infectious Disease Clinics of North America

Editorial: COVID-19: Where We Are, Where We Need to Be

COVID-19 Pathogenesis and Clinical Manifestations

SARS-CoV-2 Virology

SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant

Awakening: The Unveiling of Historically Unaddressed Social Inequities During the COVID-19 Pandemic in the United States

Infection Prevention and Control of Severe Acute Respiratory Syndrome Coronavirus 2 in Health Care Settings

Laboratory Diagnosis for SARS-CoV-2 Infection

Pharmacologic Treatment and Management of Coronavirus Disease 2019

COVID-19 in the Critically Ill Patient

Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection

COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus

COVID-19 and Pregnancy

Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children

COVID-19 Vaccines

---

Estudo de coorte | Desfechos cardiovasculares em atletas universitários 1 ano depois de infecção por SARS-CoV-2.

13 Jun, 2022 | 14:18h

Cardiovascular Outcomes in Collegiate Athletes After SARS-CoV-2 Infection: 1-Year Follow-Up From the Outcomes Registry for Cardiac Conditions in Athletes – Circulation

Comentário: A key update: 1 year later, no signs of long-term heart damage among college athletes who had COVID-19 – Cardiovascular Business

 

Comentário no Twitter

Should we worry about athletes who have had covid in the longer term?

Study shows risk of clinically relevant adverse cardiovascular outcomes over 1.2 years of follow-up is low

Surely we would review them regulalry?https://t.co/u3Mz1cFHET pic.twitter.com/5Pt4gbhIKk

— Prof Kamlesh Khunti (@kamleshkhunti) June 2, 2022

 

---